Abstract
This research project aims to explore a novel therapeutic approach to cancer proposed by Dias and colleagues in 2019 and 2024, Torres and colleagues (in preparation) and the patent number BR 10 2024 006319-8. The central proposal states that malignant cells, unlike normal cells, undergo cell death when exposed to a specific combination of a mitogen and a defined stress pathway inhibitor. …